Early results show response to new drug in patients with lymphomas and advanced solid tumours
11/21/2014
Patients with B-cell Non-Hodgkin lymphomas and advanced solid tumours have responded to a new drug that is being tested for the first time in humans in a phase I clinical trial.
Researchers identify biological indicator of response to new ovarian cancer drug
11/21/2014
Researchers have found a way of identifying which ovarian cancer patients are likely to respond well to a new anti-cancer drug called rucaparib.
Study finds more breast cancer patients opting for mastectomy
11/21/2014
Far more breast cancer patients are choosing to undergo mastectomy, including removal of both breasts, instead of choosing breast conservation surgery even when they have early stage disease that...
Umbilical cord blood from unrelated donors can halt the progression of the neurodegenerative disease Hurler syndrome if performed before the affected child is less than 9 months old, according to a...
A team led by Ludwig and Memorial Sloan Kettering (MSK) researchers has published a landmark study on the genetic basis of response to a powerful cancer therapy known as immune checkpoint blockade.
New potential target coating for drug-eluting stents identified by big data study
11/21/2014
A new study has identified an FDA approved cancer drug, crizotinib, as a possible new coating for drug-eluting stents.
The Affordable Care Act in Kentucky, one year later
11/21/2014
One year ago, Michael Stillman, M.D., and his colleague, Monalisa Tailor, M.D.
Ticagrelor halves risks of stents blocking with blood clots
11/21/2014
Treating heart attack patients with ticagrelor reduces the risk of stents blocking with blood clots according to a ground breaking new study conducted by researchers from the University of Sheffield.
Why we need to fund newer blood-thinning agents to prevent strokes
11/21/2014
Care gaps are emerging due to disharmony between healthcare reimbursement policies and evidence-based clinical guideline recommendations, cautions a group of Canadian physicians.
Patients with adverse heparin reaction before heart surgery benefit from combined strategies
11/21/2014
New evidence suggests that therapeutic plasma exchange and appropriate blood testing could help patients who are in urgent need of heart surgery, but have a history of an adverse reaction to the...